Effects of glucagon‐like peptide 1 (7–36 amide) on whole‐body protein metabolism in healthy man
The DOI matches its Crossref record.
Abstract
The incretin glucagon‐like peptide 1 (GLP‐1) shows glucose‐dependent insulinotropic activity and may exert anabolic effects. Whole‐body protein metabolism was assessed by measuring [1‐13 C]‐leucine kinetics in 13 healthy volunteers during hyperglycaemic clamping with or without pancreatic clamping (somatostatin infusion) in order to differentiate between insulin‐mediated and direct GLP‐1 effects. During intact pancreatic secretion leucine flux and leucine oxidation rate as parameters of whole‐body protein breakdown decreased markedly after 180 min of synthetic GLP‐1 infusion (GLP‐1 vs. placebo: P < 0.003). Indirect calorimetry showed an increase in energy expenditure and CO 2 production during GLP‐1 administration (P < 0.0005). Plasma insulin increased after 3 h of GLP‐1 infusion to 1486 ± 145 pmol L−1 vs. 185 ± 12 pmol L−1 for saline (P < 0.0001). When plasma insulin levels were kept constant (GLP‐1 vs. saline, NS) during pancreatic clamping, GLP‐1 effects on both protein metabolism and energy expenditure were abolished. Thus, GLP‐1 infusion in man exerts protein anticatabolic and thermic effects, which are mediated by GLP‐1‐induced stimulation of insulin secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nauck, M. A., Heimesaat, M. M., Behle, K., Holst, J. J., Nauck, M. S., Ritzel, R., Hüfner, M., & Schmiegel, W. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8355 · Cited by 605
“hyperglycemia), insulin and C-peptide concentrations increased or were maintained for at least 1 h (17, 48).”
BackgroundSelf-citationPhysiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Flint, A., Raben, A., Ersbøll, A., Holst, J., & Astrup, A. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801627 · Cited by 384
Self-citationWynne, K., Park, A. J., Small, C. J., Meeran, K., Ghatei, M. A., Frost, G. S., & Bloom, S. R. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803344 · Cited by 363
Horowitz, M., Flint, A., Jones, K. L., Hindsberger, C., Rasmussen, M. F., Kapitza, C., Doran, S., Jax, T., Zdravkovic, M., & Chapman, I. M. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.016 · Cited by 179
“The weight-loss induced by GLP-1 may potentially reflect slowing of gastric emptying [4], an increase in the perception of satiety [2], increased nausea [5], an increase in resting energy expenditure (REE) [6] and/or changes in the secretion of other gastrointestinal hormones [7].”
Background
Metadata
- Authors
- SHALEV, A., HOLST, J. J., & KELLER, U.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 1997-01
- Volume
- 27
- Issue
- 1
- Pages
- 10-16
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2018356345
- Cited by
- 61
- References
- 0
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of glucagon‐like peptide 1 (7–36 amide) on whole‐body protein metabolism in healthy man. https://app.cochat.ai/papers/10.1046/j.1365-2362.1997.540613.x
- The paper
- SHALEV, A., HOLST, J. J., & KELLER, U. (1997). Effects of glucagon‐like peptide 1 (7–36 amide) on whole‐body protein metabolism in healthy man. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.1997.540613.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.